Table 3. Characteristics of patients with and without coronary abnormalities.
A P value of <0.05 was considered significant.
| Patients with coronary abnormalities (n = 34) | Patients without coronary abnormalities (n = 30) | P-values | |
|---|---|---|---|
| Age (years)a | 3 (1.5-6) | 3.25 (2–5) | 0.840 |
| Females (n)b | 10 (29.4%) | 13 (43.3%) | 0.160 |
| Body surface area (m2)a | 0.61 (0.48–0.74) | 0.66 (0.49–0.74) | 0.466 |
| Days of fever (n)a | 14 (9.5–15) | 7 (7–12.5) | 0.008 |
| Days at IVIG administration (n)a | 12 (7.75–15.25) | 7 (5–12.5) | 0.006 |
| Hemoglobin (g/dl)a | 9.35 (8.6–11) | 11 (10–12.1) | 0.007 |
| Hematocrit (%)a | 29.95 (27-31.85) | 32 (31.1–32.25) | 0.004 |
| PLC (×103/mm3)a | 570.5 (445.5–707.5) | 301 (250.7-506) | <0.001 |
| ESR (mm/hour)a | 104.5 (94.5-120) | 60 (53–110) | 0.010 |
| TLC (×103/mm3)a | 11.5 (9.6–15) | 8.2 (6–12.9) | 0.021 |
| Pericardial Effusionb | 3 (8%) | 2 (6%) | |
| Mitral/Aortic Regurgitationb | 6 (17%) | 0 | |
| LVEDDI (mm/m2)c | 58.2 ± 15.13 | 52.4 ± 11.3 | 0.056 |
| LVESDI (mm/m2)c | 35.5 ± 11.47 | 31.1 ± 7.9 | 0.071 |
| LVFS%c | 39.2 ± 0.08 | 40.7 ± 6 (29–54) | 0.580 |
Notes.
a
median (interquartile range).
b
number (percentage).
c
mean ± standard deviations.
- ESR
- erythrocyte sedimentation rate
- IVIG
- intravenous immunoglobulin
- LVEDDI
- left-ventricular end-diastolic dimension index
- LVESDI
- left-ventricular end-systolic dimension index
- LVFS
- left-ventricular fractional shortening
- PLC
- platelet count
- TLC
- total leukocyte count